Use of prophylactic phototherapy for RhD neonatal disease in a referral service.
J Pediatr (Rio J)
; 99(1): 53-58, 2023.
Article
em En
| MEDLINE
| ID: mdl-35752322
ABSTRACT
OBJECTIVE:
This study aimed to describe the effect of prophylactic phototherapy in the treatment of infants with Neonatal Hemolytic Disease.METHOD:
A retrospective cohort study was carried out with 199 RhD-positive infants, born to RhD-negative mothers, alloimmunized for RhD antigen, between January 2009 and December 2018.RESULTS:
The incidence of exchange transfusions in the study population was 9.5%, with a mean maximum bilirubin value of 11.3 mg % (± 4.3mg %). Bilirubin's maximum peak was achieved with a mean of 119.2 life hours (± 70.6h).CONCLUSION:
The low incidence of exchange transfusion, the extended maximum bilirubin peak for later ages, and the low mean of the maximum bilirubin values may indicate a positive effect of prophylactic phototherapy in the treatment of this disease. Further studies must be carried out to confirm these findings.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Eritroblastose Fetal
/
Hiperbilirrubinemia Neonatal
Tipo de estudo:
Observational_studies
/
Risk_factors_studies
Idioma:
En
Revista:
J Pediatr (Rio J)
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Brasil